Protagonist Therapeutics, Inc. (PTGX)

Protagonist Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 21, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	2,309	2,300	1,323	537	1,632	867
Market Cap Growth	73.94%	73.94%	146.40%	-67.12%	88.21%	352.15%
Enterprise Value	1,737	1,728	1,002	274	1,286	674
Last Close Price	38.75	38.60	22.93	10.91	34.20	20.16
PE Ratio	9.16	8.36	-	-	-	-
PS Ratio	5.49	5.30	22.04	20.19	59.67	30.29
PB Ratio	4.34	4.32	3.93	2.49	5.44	3.10
P/TBV Ratio	4.32	4.32	3.93	2.49	5.44	3.10
EV/Sales Ratio	4.00	3.98	16.69	10.29	47.01	23.53
EV/EBITDA Ratio	6.84	6.81	-	-	-	-
EV/EBIT Ratio	6.87	6.83	-	-	-	-
Debt / Equity Ratio	0.02	0.02	0.00	0.02	0.02	0.02
Debt / EBITDA Ratio	0.04	0.04	-	-	-	-
Asset Turnover	-	-	0.20	0.09	0.08	0.12
Quick Ratio	-	-	16.54	7.61	7.55	7.69
Current Ratio	-	-	16.71	7.80	7.74	7.84
Return on Equity (ROE)	63.36%	63.36%	-28.59%	-49.41%	-43.32%	-36.79%
Return on Assets (ROA)	-	-	-19.32%	-27.57%	-23.40%	-16.82%
Return on Capital (ROIC)	35.89%	35.89%	-21.01%	-31.27%	-26.60%	-21.08%
Earnings Yield	11.92%	11.96%	-5.97%	-23.73%	-7.69%	-7.63%
FCF Yield	-	-5.36%	-20.29%	-6.68%	-8.41%
Buyback Yield / Dilution	-14.65%	-14.65%	-15.74%	-5.87%	-34.67%	-32.84%
Total Shareholder Return	-14.65%	-14.65%	-15.74%	-5.87%	-34.67%	-32.84%

Source: S&P Capital IQ. Standard template. Financial Sources.